{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "AMC",
  "name": "Amc Entertainment Holdings, Inc.",
  "url": "https://frontierpicks.com/dossiers/AMC/",
  "json_url": "https://frontierpicks.com/dossiers/AMC.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": "LOW",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Box-office recovery flipped from meme-squeeze dormancy to a fundamental earnings inflection: Q2 (2026-07-20) adj EPS $0.14 vs $(0.06) est, revenue $1.597B beat, plus a Wedbush $4 / Benchmark $3 upgrade cluster (2026-07-21). Narrative accelerating, but ~1B shares, ~$4B debt and post-rally ATM-dilution risk cap a chase of the post-print pop.",
  "invalidation_trigger": "A weekly close below $2.00 negates the post-Q2 breakout base and reverts the name to penny-tier grind; a fresh ATM equity-raise filing or box-office grosses rolling over across consecutive summer weekends would confirm the earnings-inflection leg has stalled.",
  "catalyst_date": null,
  "outcome": "PLAYED_OUT",
  "outcome_date": "2026-07-20",
  "invalidation_fired": false,
  "themes": [
    "freight-logistics",
    "consumer-discretionary-rotation",
    "squeeze-momentum-setups"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Share count is a moving target: 892.6M at 2026-07-22 vs 512.9M at 2025-12-31. Re-check per-share figures against the newest filing before using any multiple.",
    "GAAP and adjusted results diverge materially — Q2 2026 showed adjusted EPS $0.14 alongside a $11.4M GAAP net loss.",
    "$3.20B of principal comes due in 2029; refinancing terms, not attendance alone, drive the terminal value of the equity.",
    "Q3 2026 report date is unconfirmed — third-party calendars list dates spanning 2026-10-20 to 2026-11-11. Verify at investor.amctheatres.com.",
    "The company has funded itself via ATM and registered-direct equity in every recovery window since 2020; issuance into strength is the standing pattern."
  ],
  "body_markdown": "## Current Thesis\nThe Q2 2026 print (reported 2026-07-20) did the work the meme era never did: revenue $1,596.7M (+14.2% YoY), adjusted EBITDA $321.4M (+69.6% YoY), adjusted EPS $0.14 against a $(0.06) estimate, operating cash flow $235.4M (+70.1%) and free cash flow $190.1M. What has changed since is the market's response to the best headline the sector could produce. On 2026-08-03 the company reported its highest total revenue week in the U.S. and globally, covering July 29–Aug 2, on the back of *Spider-Man: Brand New Day* at $355M U.S. and $927M worldwide. Coverage the day before flagged a 50/200-day golden cross; coverage on 2026-08-04 framed the tape as testing $3.00 resistance. By the 2026-08-14 close of $2.50, the shares sat 20.6% below the $3.15 52-week high with RSI(14) at 49.6. A record global opening bought a test of the supply band and roughly three weeks of give-back. Against that, share count reached 892.6M at 2026-07-22 versus 512.9M at 2025-12-31, a 74.0% increase. The recovery is measured and real; the equity's claim on it keeps getting divided.\n\n## Bull Case\n- 2026-07-20 (Q2 2026): revenue $1,596.7M, +14.2% YoY; adjusted EBITDA $321.4M, +69.6% YoY; attendance 71.3M, +13.5% YoY — the operating turn is now three-line-item confirmed rather than a single EPS beat.\n- Q2 free cash flow $190.1M and operating cash flow $235.4M (+70.1% YoY) mean deleveraging no longer depends exclusively on share issuance.\n- 2026-07-24: $125.5M of 6.125% notes redeemed; principal borrowings $3.914B at 2026-06-30 versus $4.024B at 2025-12-31 (-2.7%), with the bulk — $3.20B — now sitting in 2029.\n- 2026-08-03: highest total revenue week ever recorded by the company in the U.S. and globally (July 29–Aug 2), with *Spider-Man: Brand New Day* at $355M U.S. / $927M global. Demand-side execution is not the open question.\n- 2026-08-02: golden cross per same-day technical coverage; three-month return through 2026-08-14 is +95.3%, and the post-Q2 $2.00 shelf has held on every pullback since.\n- Street high remains $4.00 against the 2026-08-14 close of $2.50 (consensus of 7 analysts, avg $2.72, low $1.80).\n\n## Bear Case\n- Supply is the binding constraint: 892.6M shares at 2026-07-22 versus 512.9M at 2025-12-31. First-half sources were 105.3M ATM shares, 95.25M in a registered direct for $200M, 142.1M via debt-for-equity swaps and 33.1M in consent fees — $334.6M of net equity proceeds.\n- Principal borrowings fell only 2.7% over six months (2025-12-31 to 2026-06-30) while share count rose 74.0%. The balance sheet is being repaired at the expense of the per-share claim.\n- GAAP net loss was $11.4M in Q2 2026 — a record-adjacent quarter that still did not clear the interest line.\n- The 2026-08-03 record week produced a $3.00 test on 2026-08-04 and then a slide to $2.50 by 2026-08-14. When the largest available demand headline cannot hold a breakout, the marginal buyer is the scarce input.\n- Consensus sits essentially on top of the tape: average target $2.72 with 2 Buy / 4 Hold / 1 Sell across 7 analysts, and a $1.80 low.\n- No scheduled corporate event until the Q3 print, with third-party calendars disagreeing across 2026-10-20 to 2026-11-11 — roughly eleven weeks of tape driven by weekend grosses and whatever the shelf does.\n\n## Setup & Price Structure\n- 2026-08-14 close $2.50; 52-week high $3.15; distance from high -20.6%; RSI(14) 49.6. Momentum has fully neutralized after the early-August spike.\n- $3.00–$3.15 is the demonstrated supply band: the 2026-08-04 test failed and price is now two-thirds of the way back toward the post-Q2 base.\n- $2.00 is the structural line carried since the 2026-07-20 print — it is where the post-earnings base was built and where the 200-day reclaim (2026-07-10) originated.\n- The 2026-08-02 golden cross arrived at the top of the advance, not ahead of it; the crossover coincided with the peak-headline day rather than preceding fresh trend.\n- The narrative is **saturated**. Mainstream retail-facing coverage clustered 2026-08-02 through 2026-08-04 (golden cross, \"Why Is AMC Stock Surging on Monday?\", \"$3.00 resistance\"), the company itself published a record-revenue release on 2026-08-03, and the tape has been lower since. New attention arrived and was absorbed.\n- Crowding/positioning observables, stated as observables: retail-sentiment coverage concentrated inside a three-session window; documented equity issuance into the H1 rally (105.3M ATM shares); share count up 74.0% since year-end; no earnings date inside 30 days, so there is no scheduled event to force repricing either way.\n\n## Catalyst Calendar (next 30 days)\n\n- 2026-08-21/23 and 2026-08-28/30 weekends — first clean domestic-gross comps after the July 29–Aug 2 record week; the question is whether attendance holds without a $900M-scale global title.\n- 2026-09-02 — *Fall 2* wide release.\n- 2026-09-04 — Adam Wingard-directed action thriller, wide release.\n- 2026-09-04 to 2026-09-07 — Labor Day weekend, the seasonal trough between the summer slate and the fall calendar.\n- ~2026-09-18 (just outside the window) — *Resident Evil* (Zach Cregger) and *Practical Magic 2*, the first material fall demand test.\n- ~2026-11-04 to ~2026-11-11 (est., unconfirmed) — Q3 2026 print, the next hard binary.\n\n## Elapsed catalysts\n\n- Undated but live: any prospectus supplement or ATM disclosure. The H1 pattern was issuance into strength, and no filing appeared in the record as of 2026-08-14. *(passed 12d ago)*\n\n## What Would Change Our Mind\nThe whole frame rests on the post-Q2 base holding while cash generation compounds. A weekly close below $2.00 removes it and returns the name to its pre-print range, where there is no obvious structural support underneath. Short of that, three observables would flip the read:\n- A new ATM or registered-direct prospectus supplement taking share count above the 892.6M reported at 2026-07-22 — that would repeat the H1 pattern and cap the equity again.\n- Two or more consecutive weekends where domestic grosses fail to hold near the July 29–Aug 2 pace, with no follow-up record-revenue release from the company.\n- Conversely, upside re-rating evidence: a September weekend that sets a fresh company record while price clears $3.15 on expanding volume, plus a Q3 filing showing share count flat against 892.6M. That combination — demand plus a closed equity spigot — is what would move the read back to accelerating.\n\n## Correlation Notes\n- Co-moves with the retail high-short-interest basket on squeeze days; management characterized the meme era as fading on 2026-07-21, so any spike without a same-day co-move in that basket is more likely box-office-driven than flow-driven.\n- Tracks the theatrical-exhibition complex (Cinemark, IMAX) on weekend-gross prints and studio-slate news; the 2026-08-03 record week was an industry event, not a company-specific one.\n- Sensitive to leveraged-credit conditions given $3.914B of principal borrowings at 2026-06-30 and a $3.20B 2029 maturity — high-yield spread widening raises the cost of the refinancing that the equity story assumes.\n- Consumer-discretionary beta applies at the ticket-and-concession line; attendance of 71.3M in Q2 is the variable that carries recession sensitivity.",
  "first_seen": "2026-04-19",
  "last_analyzed": "2026-08-16T13:53:16+00:00",
  "last_synthesized": "2026-08-16",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}